Vet Compounding Pharmacy Industry Analysis in North America

Vet Compounding Pharmacy Industry Analysis in North America by CNS Agents, Anti-infective Agents, Hormones & Substitutes, Anti-inflammatory Agents, and Others from 2024 to 2034

Analysis of Vet Compounding Pharmacy Industry Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Executive Summary

    1.1. North America Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Country Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. North America Industry Analysis 2019-2023 and Forecast, 2024-2034

    4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2019-2023

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2024-2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Product, 2019-2023

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Product, 2024-2034

        5.3.1. CNS Agents

        5.3.2. Anti-Infective Agents

        5.3.3. Hormones and Substitutes

        5.3.4. Anti-inflammatory Agents

        5.3.5. Others

    5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023

    5.5. Absolute $ Opportunity Analysis By Product, 2024-2034

6. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By Animal Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Animal Type, 2019-2023

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Animal Type, 2024-2034

        6.3.1. Companion Animals

            6.3.1.1. Dogs

            6.3.1.2. Cats

            6.3.1.3. Equine

            6.3.1.4. Others

        6.3.2. Livestock Animals

    6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2019-2023

    6.5. Absolute $ Opportunity Analysis By Animal Type, 2024-2034

7. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By End User, 2019-2023

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By End User, 2024-2034

        7.3.1. Oral

        7.3.2. Injectable

        7.3.3. Others

    7.4. Y-o-Y Growth Trend Analysis By End User, 2019-2023

    7.5. Absolute $ Opportunity Analysis By End User, 2024-2034

8. North America Industry Analysis 2019-2023 and Forecast 2024-2034, By Country

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Country, 2019-2023

    8.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Country, 2024-2034

        8.3.1. U.S.

        8.3.2. Canada

    8.4. Market Attractiveness Analysis By Country

9. U.S. Industry Analysis 2019-2023 and Forecast 2024-2034, By Region

    9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019-2023

    9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024-2034

        9.2.1. By Region

        9.2.2. By Product

        9.2.3. By Animal Type

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Region

        9.3.2. By Product

        9.3.3. By Animal Type

        9.3.4. By End User

    9.4. Key Takeaways

10. Canada Industry Analysis 2019-2023 and Forecast 2024-2034, By Region

    10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019-2023

    10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024-2034

        10.2.1. By Region

        10.2.2. By Product

        10.2.3. By Animal Type

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Region

        10.3.2. By Product

        10.3.3. By Animal Type

        10.3.4. By End User

    10.4. Key Takeaways

11. Market Structure Analysis

    11.1. Competition Dashboard

    11.2. Competition Benchmarking

    11.3. Market Share Analysis of Top Players

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Animal Type

        11.3.4. By End User

12. Competition Analysis

    12.1. Competition Deep Dive

        12.1.1. Hoye’s Pharmacy

            12.1.1.1. Overview

            12.1.1.2. Product Portfolio

            12.1.1.3. Profitability by Market Segments

            12.1.1.4. Sales Footprint

            12.1.1.5. Strategy Overview

                12.1.1.5.1. Marketing Strategy

                12.1.1.5.2. Product Strategy

                12.1.1.5.3. Channel Strategy

        12.1.2. Vertisis Custom Pharmacy

            12.1.2.1. Overview

            12.1.2.2. Product Portfolio

            12.1.2.3. Profitability by Market Segments

            12.1.2.4. Sales Footprint

            12.1.2.5. Strategy Overview

                12.1.2.5.1. Marketing Strategy

                12.1.2.5.2. Product Strategy

                12.1.2.5.3. Channel Strategy

        12.1.3. Smith Caldwell Drug Store

            12.1.3.1. Overview

            12.1.3.2. Product Portfolio

            12.1.3.3. Profitability by Market Segments

            12.1.3.4. Sales Footprint

            12.1.3.5. Strategy Overview

                12.1.3.5.1. Marketing Strategy

                12.1.3.5.2. Product Strategy

                12.1.3.5.3. Channel Strategy

        12.1.4. Sixth Avenue Medical Pharmacy

            12.1.4.1. Overview

            12.1.4.2. Product Portfolio

            12.1.4.3. Profitability by Market Segments

            12.1.4.4. Sales Footprint

            12.1.4.5. Strategy Overview

                12.1.4.5.1. Marketing Strategy

                12.1.4.5.2. Product Strategy

                12.1.4.5.3. Channel Strategy

        12.1.5. Dougherty Pharmacy

            12.1.5.1. Overview

            12.1.5.2. Product Portfolio

            12.1.5.3. Profitability by Market Segments

            12.1.5.4. Sales Footprint

            12.1.5.5. Strategy Overview

                12.1.5.5.1. Marketing Strategy

                12.1.5.5.2. Product Strategy

                12.1.5.5.3. Channel Strategy

        12.1.6. Triangle Compounding Pharmacy Inc.,

            12.1.6.1. Overview

            12.1.6.2. Product Portfolio

            12.1.6.3. Profitability by Market Segments

            12.1.6.4. Sales Footprint

            12.1.6.5. Strategy Overview

                12.1.6.5.1. Marketing Strategy

                12.1.6.5.2. Product Strategy

                12.1.6.5.3. Channel Strategy

        12.1.7. Wedgewood Pharmacy

            12.1.7.1. Overview

            12.1.7.2. Product Portfolio

            12.1.7.3. Profitability by Market Segments

            12.1.7.4. Sales Footprint

            12.1.7.5. Strategy Overview

                12.1.7.5.1. Marketing Strategy

                12.1.7.5.2. Product Strategy

                12.1.7.5.3. Channel Strategy

        12.1.8. Millers Pharmacy

            12.1.8.1. Overview

            12.1.8.2. Product Portfolio

            12.1.8.3. Profitability by Market Segments

            12.1.8.4. Sales Footprint

            12.1.8.5. Strategy Overview

                12.1.8.5.1. Marketing Strategy

                12.1.8.5.2. Product Strategy

                12.1.8.5.3. Channel Strategy

        12.1.9. Chiron Compounding Pharmacy

            12.1.9.1. Overview

            12.1.9.2. Product Portfolio

            12.1.9.3. Profitability by Market Segments

            12.1.9.4. Sales Footprint

            12.1.9.5. Strategy Overview

                12.1.9.5.1. Marketing Strategy

                12.1.9.5.2. Product Strategy

                12.1.9.5.3. Channel Strategy

        12.1.10. MEDS Canadian Compounding Pharmacy

            12.1.10.1. Overview

            12.1.10.2. Product Portfolio

            12.1.10.3. Profitability by Market Segments

            12.1.10.4. Sales Footprint

            12.1.10.5. Strategy Overview

                12.1.10.5.1. Marketing Strategy

                12.1.10.5.2. Product Strategy

                12.1.10.5.3. Channel Strategy

        12.1.11. Aurora Compounding

            12.1.11.1. Overview

            12.1.11.2. Product Portfolio

            12.1.11.3. Profitability by Market Segments

            12.1.11.4. Sales Footprint

            12.1.11.5. Strategy Overview

                12.1.11.5.1. Marketing Strategy

                12.1.11.5.2. Product Strategy

                12.1.11.5.3. Channel Strategy

13. Assumptions & Acronyms Used

14. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: North America Industry Value (US$ Million) Forecast by Country, 2019-2034

Table 02: North America Industry Volume (Unit Pack) Forecast by Country, 2019-2034

Table 03: North America Industry Value (US$ Million) Forecast by Product, 2019-2034

Table 04: North America Industry Volume (Unit Pack) Forecast by Product, 2019-2034

Table 05: North America Industry Value (US$ Million) Forecast by Animal Type, 2019-2034

Table 06: North America Industry Volume (Unit Pack) Forecast by Animal Type, 2019-2034

Table 07: North America Industry Value (US$ Million) Forecast by End User, 2019-2034

Table 08: North America Industry Volume (Unit Pack) Forecast by End User, 2019-2034

Table 09: U.S. Industry Value (US$ Million) Forecast by Region, 2019-2034

Table 10: U.S. Industry Volume (Unit Pack) Forecast by Region, 2019-2034

Table 11: U.S. Industry Value (US$ Million) Forecast by Product, 2019-2034

Table 12: U.S. Industry Volume (Unit Pack) Forecast by Product, 2019-2034

Table 13: U.S. Industry Value (US$ Million) Forecast by Animal Type, 2019-2034

Table 14: U.S. Industry Volume (Unit Pack) Forecast by Animal Type, 2019-2034

Table 15: U.S. Industry Value (US$ Million) Forecast by End User, 2019-2034

Table 16: U.S. Industry Volume (Unit Pack) Forecast by End User, 2019-2034

Table 17: Canada Industry Value (US$ Million) Forecast by Region, 2019-2034

Table 18: Canada Industry Volume (Unit Pack) Forecast by Region, 2019-2034

Table 19: Canada Industry Value (US$ Million) Forecast by Product, 2019-2034

Table 20: Canada Industry Volume (Unit Pack) Forecast by Product, 2019-2034

Table 21: Canada Industry Value (US$ Million) Forecast by Animal Type, 2019-2034

Table 22: Canada Industry Volume (Unit Pack) Forecast by Animal Type, 2019-2034

Table 23: Canada Industry Value (US$ Million) Forecast by End User, 2019-2034

Table 24: Canada Industry Volume (Unit Pack) Forecast by End User, 2019-2034

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: North America Industry Value (US$ Million) by Product, 2024-2034

Figure 02: North America Industry Value (US$ Million) by Animal Type, 2024-2034

Figure 03: North America Industry Value (US$ Million) by End User, 2024-2034

Figure 04: North America Industry Value (US$ Million) by Country, 2024-2034

Figure 05: North America Industry Value (US$ Million) Analysis by Country, 2019-2034

Figure 06: North America Industry Volume (Unit Pack) Analysis by Country, 2019-2034

Figure 07: North America Industry Value Share (%) and BPS Analysis by Country, 2024-2034

Figure 08: North America Industry Y-o-Y Growth (%) Projections by Country, 2024-2034

Figure 09: North America Industry Value (US$ Million) Analysis by Product, 2019-2034

Figure 10: North America Industry Volume (Unit Pack) Analysis by Product, 2019-2034

Figure 11: North America Industry Value Share (%) and BPS Analysis by Product, 2024-2034

Figure 12: North America Industry Y-o-Y Growth (%) Projections by Product, 2024-2034

Figure 13: North America Industry Value (US$ Million) Analysis by Animal Type, 2019-2034

Figure 14: North America Industry Volume (Unit Pack) Analysis by Animal Type, 2019-2034

Figure 15: North America Industry Value Share (%) and BPS Analysis by Animal Type, 2024-2034

Figure 16: North America Industry Y-o-Y Growth (%) Projections by Animal Type, 2024-2034

Figure 17: North America Industry Value (US$ Million) Analysis by End User, 2019-2034

Figure 18: North America Industry Volume (Unit Pack) Analysis by End User, 2019-2034

Figure 19: North America Industry Value Share (%) and BPS Analysis by End User, 2024-2034

Figure 20: North America Industry Y-o-Y Growth (%) Projections by End User, 2024-2034

Figure 21: North America Industry Attractiveness by Product, 2024-2034

Figure 22: North America Industry Attractiveness by Animal Type, 2024-2034

Figure 23: North America Industry Attractiveness by End User, 2024-2034

Figure 24: North America Industry Attractiveness by Country, 2024-2034

Figure 25: U.S. Industry Value (US$ Million) by Product, 2024-2034

Figure 26: U.S. Industry Value (US$ Million) by Animal Type, 2024-2034

Figure 27: U.S. Industry Value (US$ Million) by End User, 2024-2034

Figure 28: U.S. Industry Value (US$ Million) by Region, 2024-2034

Figure 29: U.S. Industry Value (US$ Million) Analysis by Region, 2019-2034

Figure 30: U.S. Industry Volume (Unit Pack) Analysis by Region, 2019-2034

Figure 31: U.S. Industry Value Share (%) and BPS Analysis by Region, 2024-2034

Figure 32: U.S. Industry Y-o-Y Growth (%) Projections by Region, 2024-2034

Figure 33: U.S. Industry Value (US$ Million) Analysis by Product, 2019-2034

Figure 34: U.S. Industry Volume (Unit Pack) Analysis by Product, 2019-2034

Figure 35: U.S. Industry Value Share (%) and BPS Analysis by Product, 2024-2034

Figure 36: U.S. Industry Y-o-Y Growth (%) Projections by Product, 2024-2034

Figure 37: U.S. Industry Value (US$ Million) Analysis by Animal Type, 2019-2034

Figure 38: U.S. Industry Volume (Unit Pack) Analysis by Animal Type, 2019-2034

Figure 39: U.S. Industry Value Share (%) and BPS Analysis by Animal Type, 2024-2034

Figure 40: U.S. Industry Y-o-Y Growth (%) Projections by Animal Type, 2024-2034

Figure 41: U.S. Industry Value (US$ Million) Analysis by End User, 2019-2034

Figure 42: U.S. Industry Volume (Unit Pack) Analysis by End User, 2019-2034

Figure 43: U.S. Industry Value Share (%) and BPS Analysis by End User, 2024-2034

Figure 44: U.S. Industry Y-o-Y Growth (%) Projections by End User, 2024-2034

Figure 45: U.S. Industry Attractiveness by Product, 2024-2034

Figure 46: U.S. Industry Attractiveness by Animal Type, 2024-2034

Figure 47: U.S. Industry Attractiveness by End User, 2024-2034

Figure 48: U.S. Industry Attractiveness by Region, 2024-2034

Figure 49: Canada Industry Value (US$ Million) by Product, 2024-2034

Figure 50: Canada Industry Value (US$ Million) by Animal Type, 2024-2034

Figure 51: Canada Industry Value (US$ Million) by End User, 2024-2034

Figure 52: Canada Industry Value (US$ Million) by Region, 2024-2034

Figure 53: Canada Industry Value (US$ Million) Analysis by Region, 2019-2034

Figure 54: Canada Industry Volume (Unit Pack) Analysis by Region, 2019-2034

Figure 55: Canada Industry Value Share (%) and BPS Analysis by Region, 2024-2034

Figure 56: Canada Industry Y-o-Y Growth (%) Projections by Region, 2024-2034

Figure 57: Canada Industry Value (US$ Million) Analysis by Product, 2019-2034

Figure 58: Canada Industry Volume (Unit Pack) Analysis by Product, 2019-2034

Figure 59: Canada Industry Value Share (%) and BPS Analysis by Product, 2024-2034

Figure 60: Canada Industry Y-o-Y Growth (%) Projections by Product, 2024-2034

Figure 61: Canada Industry Value (US$ Million) Analysis by Animal Type, 2019-2034

Figure 62: Canada Industry Volume (Unit Pack) Analysis by Animal Type, 2019-2034

Figure 63: Canada Industry Value Share (%) and BPS Analysis by Animal Type, 2024-2034

Figure 64: Canada Industry Y-o-Y Growth (%) Projections by Animal Type, 2024-2034

Figure 65: Canada Industry Value (US$ Million) Analysis by End User, 2019-2034

Figure 66: Canada Industry Volume (Unit Pack) Analysis by End User, 2019-2034

Figure 67: Canada Industry Value Share (%) and BPS Analysis by End User, 2024-2034

Figure 68: Canada Industry Y-o-Y Growth (%) Projections by End User, 2024-2034

Figure 69: Canada Industry Attractiveness by Product, 2024-2034

Figure 70: Canada Industry Attractiveness by Animal Type, 2024-2034

Figure 71: Canada Industry Attractiveness by End User, 2024-2034

Figure 72: Canada Industry Attractiveness by Region, 2024-2034

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Vet Compounding Pharmacy Industry Analysis in North America

Schedule a Call